pH-Sensitive Block Copolymer Micelles for Rapid Tumor Drug Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current pH-responsive micelle compositions for therapeutic and diagnostic applications face challenges such as slow drug release, low contrast sensitivity and specificity, short nanoparticle residence times, and inadequate targeting of endocytic compartments, limiting their effectiveness in cancer treatment and imaging.

Innovation Solution

Development of block copolymers forming pH-sensitive micelles with precise pH transitions and targeting moieties, allowing for rapid drug release and enhanced imaging in specific pH environments, such as tumors and endocytic compartments.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If polymer micelles release drug by hydrolysis in acidic environments, then drug delivery to tumor sites is achieved, but the release process takes days which allows the body to excrete or break down the micelles

Engineering Contradiction:
Improvedrug delivery effectivenessVSAvoidmicelle residence time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent changes the chemical parameter of the linker from hydrolysis-based to pH-cleavable bond chemistry. This allows the micelles to maintain stability during circulation (days) while enabling rapid drug release (minutes to hours) upon encountering the acidic tumor microenvironment (pH 6.5-7.0), thus resolving the contradiction between delivery reliability and time loss

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The micelle system transitions from a static, slowly degrading structure to a dynamic system that responds to pH changes. The pH-cleavable linkers remain intact at physiological pH but rapidly cleave at acidic pH, creating a dynamic release mechanism that adapts to the tumor microenvironment while maintaining circulation stability

Inventive Principle:
Principle #15Dynamics

2Measurement precision

If conventional imaging probes are used, then tumor imaging is achieved, but contrast sensitivity and specificity are low

Engineering Contradiction:
Improveimaging contrast sensitivityVSAvoidnanoparticle composition complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines multiple functions into a single nanoparticle system: pH-responsive drug delivery, tumor targeting, and high-contrast imaging. The imaging probe is integrated into the micelle structure itself, eliminating the need for separate imaging agents and enhancing contrast sensitivity through the synergistic effect of targeted accumulation and pH-activated signal generation

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The nanoparticle comprises a composite structure with hydrophilic and hydrophobic blocks, pH-cleavable linkers, and imaging probe moieties. This composite material design enables simultaneous achievement of stable circulation, rapid pH-triggered drug release, and enhanced imaging contrast, resolving the contradiction between measurement precision and device complexity

Inventive Principle:
Principle #40Composite materials

3Productivity

If nanoparticles are designed for rapid drug release, then therapeutic efficacy is improved, but nanoparticle residence time in circulation decreases

Engineering Contradiction:
Improvedrug release rateVSAvoidnanoparticle circulation time
Core Design Contradiction:
ProductivityVSDuration of action of stationary object

Solution Approach 1:

The patent employs pH-cleavable linkers that exploit the parameter difference between physiological pH (7.4) and tumor microenvironment pH (6.5-7.0). The linkers remain stable at physiological pH during circulation but undergo rapid cleavage at acidic pH, enabling fast drug release only at the target site while maintaining long circulation half-life in the bloodstream

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The pH-cleavable linker acts as an intermediary that mediates between the stable micelle structure during circulation and the rapid drug release at the tumor site. This intermediary mechanism allows the system to maintain stability during transport while enabling fast release upon encountering the acidic tumor microenvironment, resolving the contradiction between productivity and duration of action

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The micelles provide rapid drug delivery and increased imaging sensitivity and specificity by disassociating within minutes in acidic environments, enhancing therapeutic efficacy and diagnostic accuracy.

Implementation Method 1

block copolymers forming pH-sensitive micelles

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Implementation Method 2

micelles provide rapid drug delivery and increased imaging sensitivity and specificity by disassociating within minutes in acidic environments

Methodology Applied
Scientific EffectpH-induced micelle disassociation: Phase Change

Data Source

PatentUS12528903B2Block copolymer and micelle compositions and methods of use thereof
Publication Date: 2026.01.20 BOARD OF RGT THE UNIV OF TEXAS SYST
  • US12528903B2 patent drawing
  • US12528903B2 patent drawing
  • US12528903B2 patent drawing

AI summary

Provided herein are block copolymers comprising a hydrophilic polymer segment and a hydrophobic polymer segment, wherein the hydrophilic polymer segment comprises a polymer selected from the group consisting of: poly(ethylene oxide) (PEO), poly(methacrylate phosphatidyl choline) (MPC), and polyvinylpyrrolidone (PVP), wherein the hydrophobic polymer segment compriseswherein R′ is —H or —CH3, wherein R is —NR1R2, wherein R1 and R2 are alkyl groups, wherein R1 and R2 are the same or different, wherein R1 and R2 together have from 5 to 16 carbons, wherein R1 and R2 may optionally join to form a ring, wherein n is 1 to about 10, and wherein x is about 20 to about 200 in total. Also provided are pH-sensitive micelle compositions for therapeutic and diagnostic applications.